XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders’ Equity (Deficit) (Tables)
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Schedule of fair value calculations for the stock options granted

   Six Months Ended
June 30,
2019
 
Risk free interest rate   2.30%
Expected life (years)   6.1 
Expected volatility   191.65%
Expected dividend yield   None 

Schedule of allocation of stock-based compensation expense

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2020   2019   2020   2019 
Research and development  $2   $8   $5   $17 
General and administrative  $12   $32   $28   $73 
Director and consultant options  $3   $8   $6   $17 
Total stock-based compensation expense  $17   $48   $39   $107 

Schedule of option activity under the Company's plans

   2020   2019 

Options

 

Shares

  

Weighted Average Exercise Price Per Share

   Weighted Average Remaining Contractual Life (Years)  

Aggregate Intrinsic Value

  

Shares

  

Weighted Average Exercise Price Per Share

   Weighted Average Remaining Contractual Life (Years)  

Aggregate Intrinsic Value

 
Outstanding at January 1,   1,077   $1.59    -   $

 

         

    1,037   $1.65        $- 
Granted   -   $-    -   $    40   $0.50        $- 
Forfeited or expired   10   $56.10    -   $    -   $-        $- 
Outstanding at June 30   1,067   $1.07    5.50   $    1,070   $1.61    5.50   $- 
Vested and expected to vest at June 30   1,067   $1.07    4.52   $-    1,070   $1.61    5.50   $- 
Exercisable at June 30   822   $1.18    4.38   $-    489   $2.77    5.16   $- 

Schedule of significant ranges of outstanding and exercisable options

   Options Outstanding   Options Exercisable 
Range of Exercise Prices  Number Outstanding   Weighted Average Remaining Contractual Term (in years)   Weighted Average Exercise Price per share   Number Outstanding   Weighted Average Exercise Price per Share 
$0.01 – $0.50   655    4.24   $0.50    574   $0.50 
$0.51 – $625.00   412    4.92   $1.97    229   $9.20 
Total   1,067    4.52   $1.07    822   $2.77 

Schedule of the company's non-vested shares

Non-vested Shares  Shares   Weighted Average
Grant-Date
Fair Value per share
 
Non-vested at January 1, 2020   417   $0.65 
Vested   (172)  $0.69 
Non-vested at June 30, 2020   245   $0.69 

Schedule of warrant activity

   2020   2019 
   Shares   Weighted Average Exercise Price Per Share   Shares   Weighted Average Exercise Price Per Share 
Outstanding at beginning of period   2,536   $1.52    1,828   $2.08 
Issued   30   $-    985   $0.50 
Expired   -   $-    -   $- 
Outstanding at end of period   2,566   $1.52    2,813   $1.58 
Exercisable at end of period   2,566   $1.52    2,813   $1.58 

Schedule of warrants outstanding and exercisable

Number of Warrants   Weighted Average Remaining Life (years)   Weighted Average Exercise Price per share 
          
 1,551    0.89   $2.18 
 985    1.63   $0.50 
 30    2.61   $0.50 
 2,566    1.20   $1.51